Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 3, 2011, Pages 848-870

  Balu, Darrick T ^a,b   Coyle, Joseph T ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Akt1; BDNF; DISC 1; Dysbindin; ErbB4; Neuregulin; NMDA receptor; Schizophrenia

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DYSBINDIN; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVB; PROTEIN 14 3 3; PROTEIN 14 3 3 EPSILON; PROTEIN KINASE B; UNCLASSIFIED DRUG;

CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; DENDRITIC SPINE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; FRONTAL CORTEX; GABAERGIC TRANSMISSION; GENE EXPRESSION REGULATION; GENETIC RISK; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MYELINATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; SYNAPTOGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 78649906486     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.10.005     Document Type: Review

References (321)

1. Abe Y., Namba H., Zheng Y., Nawa H. In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 2009, 161:95-110.
2. Adachi K., Mirzadeh Z., Sakaguchi M., Yamashita T., Nikolcheva T., Gotoh Y., Peltz G., Gong L., Kawase T., Alvarez-Buylla A., Okano H., Sawamoto K. Beta-catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells 2007, 25:2827-2836.
3. Aid T., Kazantseva A., Piirsoo M., Palm K., Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 2007, 85:525-535.
4. Alaerts M., Ceulemans S., Forero D., Moens L.N., De Zutter S., Heyrman L., Lenaerts A.S., Norrback K.F., De Rijk P., Nilsson L.G., Goossens D., Adolfsson R., Del-Favero J. Support for NRG1 as a susceptibility factor for schizophrenia in a northern Swedish isolated population. Arch. Gen. Psychiatry 2009, 66:828-837.
5. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40:827-834.
6. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997, 389:856-860.
7. An J.J., Gharami K., Liao G.Y., Woo N.H., Lau A.G., Vanevski F., Torre E.R., Jones K.R., Feng Y., Lu B., Xu B. Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 2008, 134:175-187.
8. Anton E.S., Ghashghaei H.T., Weber J.L., McCann C., Fischer T.M., Cheung I.D., Gassmann M., Messing A., Klein R., Schwab M.H., Lloyd K.C., Lai C. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat. Neurosci. 2004, 7:1319-1328.
9. Anton E.S., Marchionni M.A., Lee K.F., Rakic P. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 1997, 124:3501-3510.
10. Aoki C., Wu K., Elste A., Len G., Lin S., McAuliffe G., Black I.B. Localization of brain-derived neurotrophic factor and TrkB receptors to postsynaptic densities of adult rat cerebral cortex. J. Neurosci. Res. 2000, 59:454-463.
11. Arguello P.A., Gogos J.A. A signaling pathway AKTing up in schizophrenia. J. Clin. Invest. 2008, 118:2018-2021.
12. Asnaghi L., Bruno P., Priulla M., Nicolin A. mTOR: a protein kinase switching between life and death. Pharmacol. Res. 2004, 50:545-549.
13. Austin C.P., Ma L., Ky B., Morris J.A., Shughrue P.J. DISC1 (Disrupted in Schizophrenia-1) is expressed in limbic regions of the primate brain. Neuroreport 2003, 14:951-954.
14. Baillie G.S., Scott J.D., Houslay M.D. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Lett. 2005, 579:3264-3270.
15. Bajestan S.N., Sabouri A.H., Nakamura M., Takashima H., Keikhaee M.R., Behdani F., Fayyazi M.R., Sargolzaee M.R., Bajestan M.N., Sabouri Z., Khayami E., Haghighi S., Hashemi S.B., Eiraku N., Tufani H., Najmabadi H., Arimura K., Sano A., Osame M. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:383-386.
16. Balu D.T., Lucki I. Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neurosci. Biobehav. Rev. 2009, 33:232-252.
17. Balu D.T., Carlson G.C., Talbot K., Kazi H., Hill-Smith T.E., Easton R.M., Birnbaum M.J., Lucki I. Akt1 deficiency and in schizophrenia and impairment of hippocampal plasticity and function. Hippocampus 2010, 10.1002/hipo.20887.
18. Basu A.C., Tsai G.E., Ma C.L., Ehmsen J.T., Mustafa A.K., Han L., Jiang Z.I., Benneyworth M.A., Froimowitz M.P., Lange N., Snyder S.H., Bergeron R., Coyle J.T. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol. Psychiatry 2009, 14:719-727.
19. Beaulieu J.M., Gainetdinov R.R., Caron M.G. Akt/GSK3 signaling in the action of psychotropic drugs. Annu. Rev. Pharmacol. Toxicol. 2009, 49:327-347.
20. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005, 122:261-273.
21. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:5099-5104.
22. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25:1-27.
23. Benson M.A., Newey S.E., Martin-Rendon E., Hawkes R., Blake D.J. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem. 2001, 276:24232-24241.
24. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T., Frank J.A., Tedeschi G., Weinberger D.R. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry 1996, 153:1554-1563.
25. Bertram I., Bernstein H.G., Lendeckel U., Bukowska A., Dobrowolny H., Keilhoff G., Kanakis D., Mawrin C., Bielau H., Falkai P., Bogerts B. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression. Ann. N. Y. Acad. Sci. 2007, 1096:147-156.
26. Bhardwaj S.K., Baharnoori M., Sharif-Askari B., Kamath A., Williams S., Srivastava L.K. Behavioral characterization of dysbindin-1 deficient sandy mice. Behav. Brain Res. 2009, 197:435-441.
27. Binder D.K., Scharfman H.E. Brain-derived neurotrophic factor. Growth Factors 2004, 22:123-131.
28. Bjarnadottir M., Misner D.L., Haverfield-Gross S., Bruun S., Helgason V.G., Stefansson H., Sigmundsson A., Firth D.R., Nielsen B., Stefansdottir R., Novak T.J., Stefansson K., Gurney M.E., Andresson T. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. J. Neurosci. 2007, 27:4519-4529.
29. Bloom L., Horvitz H.R. The Caenorhabditis elegans gene unc-76 and its human homologs define a new gene family involved in axonal outgrowth and fasciculation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:3414-3419.
30. Bradley J., Carter S.R., Rao V.R., Wang J., Finkbeiner S. Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression. J. Neurosci. 2006, 26:1065-1076.
31. Brandon N.J., Handford E.J., Schurov I., Rain J.C., Pelling M., Duran-Jimeniz B., Camargo L.M., Oliver K.R., Beher D., Shearman M.S., Whiting P.J. Disrupted in Schizophrenia 1 and nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol. Cell. Neurosci. 2004, 25:42-55.
32. Brandon N.J., Millar J.K., Korth C., Sive H., Singh K.K., Sawa A. Understanding the role of DISC1 in psychiatric disease and during normal development. J. Neurosci. 2009, 29:12768-12775.
33. Bray N.J., Preece A., Williams N.M., Moskvina V., Buckland P.R., Owen M.J., O'Donovan M.C. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum. Mol. Genet. 2005, 14:1947-1954.
34. Brinkmann B.G., Agarwal A., Sereda M.W., Garratt A.N., Muller T., Wende H., Stassart R.M., Nawaz S., Humml C., Velanac V., Radyushkin K., Goebbels S., Fischer T.M., Franklin R.J., Lai C., Ehrenreich H., Birchmeier C., Schwab M.H., Nave K.A. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 2008, 59:581-595.
35. Buckley P.F., Moore C., Long H., Larkin C., Thompson P., Mulvany F., Redmond O., Stack J.P., Ennis J.T., Waddington J.L. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol. Psychiatry 1994, 36:792-800.
36. Buckley P.F., Pillai A., Evans D., Stirewalt E., Mahadik S. Brain derived neurotropic factor in first-episode psychosis. Schizophr. Res. 2007, 91:1-5.
37. Burdick K.E., Goldberg T.E., Funke B., Bates J.A., Lencz T., Kucherlapati R., Malhotra A.K. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr. Res. 2007, 89:169-172.
38. Burdick K.E., Kamiya A., Hodgkinson C.A., Lencz T., DeRosse P., Ishizuka K., Elashvili S., Arai H., Goldman D., Sawa A., Malhotra A.K. Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding. Hum. Mol. Genet. 2008, 17:2462-2473.
39. Burdick K.E., Lencz T., Funke B., Finn C.T., Szeszko P.R., Kane J.M., Kucherlapati R., Malhotra A.K. Genetic variation in DTNBP1 influences general cognitive ability. Hum. Mol. Genet. 2006, 15:1563-1568.
40. Caldeira M.V., Melo C.V., Pereira D.B., Carvalho R., Correia S.S., Backos D.S., Carvalho A.L., Esteban J.A., Duarte C.B. Brain-derived neurotrophic factor regulates the expression and synaptic delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons. J. Biol. Chem. 2007, 282:12619-12628.
41. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., Goldberg T.E., Weinberger D.R. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8627-8632.
42. Camargo L.M., Collura V., Rain J.C., Mizuguchi K., Hermjakob H., Kerrien S., Bonnert T.P., Whiting P.J., Brandon N.J. Disrupted in Schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 2007, 12:74-86.
43. Cannon T.D., Hennah W., van Erp T.G., Thompson P.M., Lonnqvist J., Huttunen M., Gasperoni T., Tuulio-Henriksson A., Pirkola T., Toga A.W., Kaprio J., Mazziotta J., Peltonen L. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch. Gen. Psychiatry 2005, 62:1205-1213.
44. Cannon T.D. Candidate gene studies in the GWAS era: the MET proto-oncogene, neurocognition, and schizophrenia. Am. J. Psychiatry 2010, 167:369-372.
45. Chen D.C., Wang J., Wang B., Yang S.C., Zhang C.X., Zheng Y.L., Li Y.L., Wang N., Yang K.B., Xiu M.H., Kosten T.R., Zhang X.Y. Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl) 2009, 207:375-380.
46. Chen X.W., Feng Y.Q., Hao C.J., Guo X.L., He X., Zhou Z.Y., Guo N., Huang H.P., Xiong W., Zheng H., Zuo P.L., Zhang C.X., Li W., Zhou Z. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J. Cell. Biol. 2008, 181:791-801.
47. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
48. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
49. Cho H., Thorvaldsen J.L., Chu Q., Feng F., Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 2001, 276:38349-38352.
50. Chong V.Z., Thompson M., Beltaifa S., Webster M.J., Law A.J., Weickert C.S. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr. Res. 2008, 100:270-280.
51. Chubb J.E., Bradshaw N.J., Soares D.C., Porteous D.J., Millar J.K. The DISC locus in psychiatric illness. Mol. Psychiatry 2008, 13:36-64.
52. Chudasama Y., Robbins T.W. Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol. Psychol. 2006, 73:19-38.
53. Ciani L., Salinas P.C. WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat. Rev. Neurosci. 2005, 6:351-362.
54. Coffer P.J., Jin J., Woodgett J.R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 1998, 335(Pt 1):1-13.
55. Compte A., Brunel N., Goldman-Rakic P.S., Wang X.J. Synaptic mechanisms and network dynamics underlying spatial working memory in a cortical network model. Cereb. Cortex 2000, 10:910-923.
56. Cox M.M., Tucker A.M., Tang J., Talbot K., Richer D.C., Yeh L., Arnold S.E. Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav. 2009, 8:390-397.
57. Curtis D., Kalsi G., Brynjolfsson J., McInnis M., O'Neill J., Smyth C., Moloney E., Murphy P., McQuillin A., Petursson H., Gurling H. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr. Genet. 2003, 13:77-84.
58. Dammermann A., Merdes A. Assembly of centrosomal proteins and microtubule organization depends on PCM-1. J. Cell. Biol. 2002, 159:255-266.
59. Datta S.R., McQuillin A., Rizig M., Blaveri E., Thirumalai S., Kalsi G., Lawrence J., Bass N.J., Puri V., Choudhury K., Pimm J., Crombie C., Fraser G., Walker N., Curtis D., Zvelebil M., Pereira A., Kandaswamy R., St Clair D., Gurling H.M. A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia. Mol. Psychiatry 2010, 15:615-628.
60. Davis M., Ressler K., Rothbaum B.O., Richardson R. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol. Psychiatry 2006, 60:369-375.
61. Davis R.L. Physiology and biochemistry of Drosophila learning mutants. Physiol. Rev. 1996, 76:299-317.
62. Dempster E., Toulopoulou T., McDonald C., Bramon E., Walshe M., Filbey F., Wickham H., Sham P.C., Murray R.M., Collier D.A. Association between BDNF val66 met genotype and episodic memory. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 134B:73-75.
63. DeRosse P., Funke B., Burdick K.E., Lencz T., Ekholm J.M., Kane J.M., Kucherlapati R., Malhotra A.K. Dysbindin genotype and negative symptoms in schizophrenia. Am. J. Psychiatry 2006, 163:532-534.
64. Desbonnet L., Waddington J.L., Tuathaigh C.M. Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes?. Behav. Brain Res. 2009, 204:258-273.
65. Detera-Wadleigh S.D., Badner J.A., Berrettini W.H., Yoshikawa T., Goldin L.R., Turner G., Rollins D.Y., Moses T., Sanders A.R., Karkera J.D., Esterling L.E., Zeng J., Ferraro T.N., Guroff J.J., Kazuba D., Maxwell M.E., Nurnberger J.I., Gershon E.S. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:5604-5609.
66. DeVito L.M., Balu D.T., Kanter B.R., Lykken C., Basu A.C., Coyle J.T., Eichenbaum H. Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav. 2010, 10.1111/j.1601-183X.2010.00656.x.
67. Dickman D.K., Davis G.W. The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis. Science 2009, 326:1127-1130.
68. Donohoe G., Frodl T., Morris D., Spoletini I., Cannon D.M., Cherubini A., Caltagirone C., Bossu P., McDonald C., Gill M., Corvin A.P., Spalletta G. Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia. Neuropsychopharmacology 2009, 35:368-373.
69. Donohoe G., Morris D.W., Clarke S., McGhee K.A., Schwaiger S., Nangle J.M., Garavan H., Robertson I.H., Gill M., Corvin A. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia 2007, 45:454-458.
70. Doxsey S. Re-evaluating centrosome function. Nat. Rev. Mol. Cell. Biol. 2001, 2:688-698.
71. Drake C.T., Milner T.A., Patterson S.L. Ultrastructural localization of full-length trkB immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic plasticity. J. Neurosci. 1999, 19:8009-8026.
72. Duan X., Chang J.H., Ge S., Faulkner R.L., Kim J.Y., Kitabatake Y., Liu X.B., Yang C.H., Jordan J.D., Ma D.K., Liu C.Y., Ganesan S., Cheng H.J., Ming G.L., Lu B., Song H. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 2007, 130:1146-1158.
73. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., Thome J. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr. Res. 2001, 52:79-86.
74. Easton R.M., Cho H., Roovers K., Shineman D.W., Mizrahi M., Forman M.S., Lee V.M., Szabolcs M., de Jong R., Oltersdorf T., Ludwig T., Efstratiadis A., Birnbaum M.J. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell. Biol. 2005, 25:1869-1878.
75. Eastwood S.L., Hodgkinson C.A., Harrison P.J. DISC-1 Leu607Phe alleles differentially affect centrosomal PCM1 localization and neurotransmitter release. Mol. Psychiatry 2009, 14:556-557.
76. Eastwood S.L., Walker M., Hyde T.M., Kleinman J.E., Harrison P.J. The DISC1 Ser704Cys substitution affects centrosomal localization of its binding partner PCM1 in glia in human brain. Hum. Mol. Genet. 2010, 19:2487-2496.
77. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
78. Eide F.F., Vining E.R., Eide B.L., Zang K., Wang X.Y., Reichardt L.F. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J. Neurosci. 1996, 16:3123-3129.
79. Ekelund J., Hennah W., Hiekkalinna T., Parker A., Meyer J., Lonnqvist J., Peltonen L. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol. Psychiatry 2004, 9:1037-1041.
80. Ekelund J., Hovatta I., Parker A., Paunio T., Varilo T., Martin R., Suhonen J., Ellonen P., Chan G., Sinsheimer J.S., Sobel E., Juvonen H., Arajarvi R., Partonen T., Suvisaari J., Lonnqvist J., Meyer J., Peltonen L. Chromosome 1 loci in Finnish schizophrenia families. Hum. Mol. Genet. 2001, 10:1611-1617.
81. Ekelund J., Lichtermann D., Hovatta I., Ellonen P., Suvisaari J., Terwilliger J.D., Juvonen H., Varilo T., Arajarvi R., Kokko-Sahin M.L., Lonnqvist J., Peltonen L. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum. Mol. Genet. 2000, 9:1049-1057.
82. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004, 36:131-137.
83. Enomoto A., Asai N., Namba T., Wang Y., Kato T., Tanaka M., Tatsumi H., Taya S., Tsuboi D., Kuroda K., Kaneko N., Sawamoto K., Miyamoto R., Jijiwa M., Murakumo Y., Sokabe M., Seki T., Kaibuchi K., Takahashi M. Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus. Neuron 2009, 63:774-787.
84. Fallgatter A.J., Ehlis A.C., Herrmann M.J., Hohoff C., Reif A., Freitag C.M., Deckert J. DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in schizophrenic patients - support for the glutamate hypothesis of schizophrenias. Genes Brain Behav. 2010, 9:489-497.
85. Fanous A.H., van den Oord E.J., Riley B.P., Aggen S.H., Neale M.C., O'Neill F.A., Walsh D., Kendler K.S. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am. J. Psychiatry 2005, 162:1824-1832.
86. Fazzari P., Paternain A.V., Valiente M., Pla R., Lujan R., Lloyd K., Lerma J., Marin O., Rico B. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 2010, 464:1376-1380.
87. Feng Y.Q., Zhou Z.Y., He X., Wang H., Guo X.L., Hao C.J., Guo Y., Zhen X.C., Li W. Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia. Schizophr. Res. 2008, 106:218-228.
88. Fisahn A., Neddens J., Yan L., Buonanno A. Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb. Cortex 2009, 19:612-618.
89. Flames N., Long J.E., Garratt A.N., Fischer T.M., Gassmann M., Birchmeier C., Lai C., Rubenstein J.L., Marin O. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 2004, 44:251-261.
90. Fuster J.M. The prefrontal cortex - an update: time is of the essence. Neuron 2001, 30:319-333.
91. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R., Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry 1998, 65:446-453.
92. Ghashghaei H.T., Weber J., Pevny L., Schmid R., Schwab M.H., Lloyd K.C., Eisenstat D.D., Lai C., Anton E.S. The role of neuregulin-ErbB4 interactions on the proliferation and organization of cells in the subventricular zone. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1930-1935.
93. Ghiani C.A., Starcevic M., Rodriguez-Fernandez I.A., Nazarian R., Cheli V.T., Chan L.N., Malvar J.S., de Vellis J., Sabatti C., Dell'angelica E.C. The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. Mol. Psychiatry 2009, 15:115. 204-215.
94. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
95. Golding J.P., Trainor P., Krumlauf R., Gassmann M. Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4. Nat. Cell. Biol. 2000, 2:103-109.
96. Goldman A.L., Pezawas L., Mattay V.S., Fischl B., Verchinski B.A., Chen Q., Weinberger D.R., Meyer-Lindenberg A. Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch. Gen. Psychiatry 2009, 66:467-477.
97. Gong Y.G., Wu C.N., Xing Q.H., Zhao X.Z., Zhu J., He L. A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia. Schizophr. Res. 2009, 111:109-114.
98. Gorba T., Wahle P. Expression of TrkB and TrkC but not BDNF mRNA in neurochemically identified interneurons in rat visual cortex in vivo and in organotypic cultures. Eur. J. Neurosci. 1999, 11:1179-1190.
99. Gratacos M., Gonzalez J.R., Mercader J.M., de Cid R., Urretavizcaya M., Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 2007, 61:911-922.
100. Greer P.L., Greenberg M.E. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 2008, 59:846-860.
101. Grillo R.W., Ottoni G.L., Leke R., Souza D.O., Portela L.V., Lara D.R. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J. Psychiatr. Res. 2007, 41:31-35.
102. Guo A.Y., Sun J., Riley B.P., Thiselton D.L., Kendler K.S., Zhao Z. The dystrobrevin-binding protein 1 gene: features and networks. Mol. Psychiatry 2009, 14:18-29.
103. Gurling H.M., Critchley H., Datta S.R., McQuillin A., Blaveri E., Thirumalai S., Pimm J., Krasucki R., Kalsi G., Quested D., Lawrence J., Bass N., Choudhury K., Puri V., O'Daly O., Curtis D., Blackwood D., Muir W., Malhotra A.K., Buchanan R.W., Good C.D., Frackowiak R.S., Dolan R.J. Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. Arch. Gen. Psychiatry 2006, 63:844-854.
104. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., Bakshi K., Kamins J., Borgmann-Winter K.E., Siegel S.J., Gallop R.J., Arnold S.E. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 2006, 12:824-828.
105. Hall J., Whalley H.C., Job D.E., Baig B.J., McIntosh A.M., Evans K.L., Thomson P.A., Porteous D.J., Cunningham-Owens D.G., Johnstone E.C., Lawrie S.M. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 2006, 9:1477-1478.
106. Hamshere M.L., Bennett P., Williams N., Segurado R., Cardno A., Norton N., Lambert D., Williams H., Kirov G., Corvin A., Holmans P., Jones L., Jones I., Gill M., O'Donovan M.C., Owen M.J., Craddock N. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch. Gen. Psychiatry 2005, 62:1081-1088.
107. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 2006, 60:132-140.
108. Hashimoto R., Numakawa T., Ohnishi T., Kumamaru E., Yagasaki Y., Ishimoto T., Mori T., Nemoto K., Adachi N., Izumi A., Chiba S., Noguchi H., Suzuki T., Iwata N., Ozaki N., Taguchi T., Kamiya A., Kosuga A., Tatsumi M., Kamijima K., Weinberger D.R., Sawa A., Kunugi H. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum. Mol. Genet. 2006, 15:3024-3033.
109. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 2005, 25:372-383.
110. Hattori T., Baba K., Matsuzaki S., Honda A., Miyoshi K., Inoue K., Taniguchi M., Hashimoto H., Shintani N., Baba A., Shimizu S., Yukioka F., Kumamoto N., Yamaguchi A., Tohyama M., Katayama T. A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth. Mol. Psychiatry 2007, 12:398-407.
111. Hattori T., Shimizu S., Koyama Y., Yamada K., Kuwahara R., Kumamoto N., Matsuzaki S., Ito A., Katayama T., Tohyama M. DISC1 regulates cell-cell adhesion, cell-matrixadhesion and neurite outgrowth. Mol. Psychiatry 2010, 15:778. 798-809.
112. Hawi Z., Straub R.E., O'Neill A., Kendler K.S., Walsh D., Gill M. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Res. 1998, 81:111-116.
113. Hayashi-Takagi A., Takaki M., Graziane N., Seshadri S., Murdoch H., Dunlop A.J., Makino Y., Seshadri A.J., Ishizuka K., Srivastava D.P., Xie Z., Baraban J.M., Houslay M.D., Tomoda T., Brandon N.J., Kamiya A., Yan Z., Penzes P., Sawa A. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 2010, 13:327-332.
114. Higginbotham H.R., Gleeson J.G. The centrosome in neuronal development. Trends Neurosci. 2007, 30:276-283.
115. Hill J.J., Kolluri N., Hashimoto T., Wu Q., Sampson A.R., Monteggia L.M., Lewis D.A. Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor. Biol. Psychiatry 2005, 57:932-934.
116. Ho B.C., Andreasen N.C., Dawson J.D., Wassink T.H. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am. J. Psychiatry 2007, 164:1890-1899.
117. Ho B.C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch. Gen. Psychiatry 2006, 63:731-740.
118. Hodgkinson C.A., Goldman D., Ducci F., DeRosse P., Caycedo D.A., Newman E.R., Kane J.M., Roy A., Malhotra A.K. The FEZ1 gene shows no association to schizophrenia in Caucasian or African American populations. Neuropsychopharmacology 2007, 32:190-196.
119. Holm M.M., Nieto-Gonzalez J.L., Vardya I., Vaegter C.B., Nykjaer A., Jensen K. Mature BDNF, but not proBDNF, reduces excitability of fast-spiking interneurons in mouse dentate gyrus. J. Neurosci. 2009, 29:12412-12418.
120. Hong C.J., Yu Y.W., Lin C.H., Tsai S.J. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 2003, 349:206-208.
121. Houslay M.D., Adams D.R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 2003, 370:1-18.
122. Hovatta I., Varilo T., Suvisaari J., Terwilliger J.D., Ollikainen V., Arajarvi R., Juvonen H., Kokko-Sahin M.L., Vaisanen L., Mannila H., Lonnqvist J., Peltonen L. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am. J. Hum. Genet. 1999, 65:1114-1124.
123. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 2003, 72:609-642.
124. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., Mei L. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000, 26:443-455.
125. Huang Z.J., Kirkwood A., Pizzorusso T., Porciatti V., Morales B., Bear M.F., Maffei L., Tonegawa S. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 1999, 98:739-755.
126. Hwu H.G., Liu C.M., Fann C.S., Ou-Yang W.C., Lee S.F. Linkage of schizophrenia with chromosome 1q loci in Taiwanese families. Mol. Psychiatry 2003, 8:445-452.
127. Ide M., Ohnishi T., Murayama M., Matsumoto I., Yamada K., Iwayama Y., Dedova I., Toyota T., Asada T., Takashima A., Yoshikawa T. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J. Neurochem. 2006, 99:277-287.
128. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Inada T., Ozaki N. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol. Psychiatry 2004, 56:698-700.
129. Ikeda Y., Yahata N., Ito I., Nagano M., Toyota T., Yoshikawa T., Okubo Y., Suzuki H. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr. Res. 2008, 101:58-66.
130. Iona S., Cuomo M., Bushnik T., Naro F., Sette C., Hess M., Shelton E.R., Conti M. Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain. Mol. Pharmacol. 1998, 53:23-32.
131. Ishizuka K., Chen J., Taya S., Li W., Millar J.K., Xu Y., Clapcote S.J., Hookway C., Morita M., Kamiya A., Tomoda T., Lipska B.K., Roder J.C., Pletnikov M., Porteous D., Silva A.J., Cannon T.D., Kaibuchi K., Brandon N.J., Weinberger D.R., Sawa A. Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol. Psychiatry 2007, 12:897-899.
132. Iwata N., Suzuki T., Ikeda M., Kitajima T., Yamanouchi Y., Inada T., Ozaki N. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol. Psychiatry 2004, 9:126-127.
133. Jaaro-Peled H. Gene models of schizophrenia: DISC1 mouse models. Prog. Brain Res. 2009, 179:75-86.
134. Jaaro-Peled H., Ayhan Y., Pletnikov M.V., Sawa A. Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. Schizophr. Bull. 2010, 36:301-313.
135. Jaaro-Peled H., Hayashi-Takagi A., Seshadri S., Kamiya A., Brandon N.J., Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci. 2009, 32:485-495.
136. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148:1301-1308.
137. Jay T.M. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog. Neurobiol. 2003, 69:375-390.
138. Jentsch J.D., Trantham-Davidson H., Jairl C., Tinsley M., Cannon T.D., Lavin A. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice. Neuropsychopharmacology 2009, 34:2601-2608.
139. Ji Y., Yang F., Papaleo F., Wang H.X., Gao W.J., Weinberger D.R., Lu B. Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19593-19598.
140. Jones K.R., Farinas I., Backus C., Reichardt L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 1994, 76:989-999.
141. Jonsson E.G., Edman-Ahlbom B., Sillen A., Gunnar A., Kulle B., Frigessi A., Vares M., Ekholm B., Wode-Helgodt B., Schumacher J., Cichon S., Agartz I., Sedvall G.C., Hall H., Terenius L. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:924-933.
142. Kalus P., Muller T.J., Zuschratter W., Senitz D. The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport 2000, 11:3621-3625.
143. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., Ross C.A., Hatten M.E., Nakajima K., Sawa A. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell. Biol. 2005, 7:1167-1178.
144. Kamiya A., Tan P.L., Kubo K., Engelhard C., Ishizuka K., Kubo A., Tsukita S., Pulver A.E., Nakajima K., Cascella N.G., Katsanis N., Sawa A. Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: a candidate for psychiatric illnesses. Arch. Gen. Psychiatry 2008, 65:996-1006.
145. Kamiya A., Tomoda T., Chang J., Takaki M., Zhan C., Morita M., Cascio M.B., Elashvili S., Koizumi H., Takanezawa Y., Dickerson F., Yolken R., Arai H., Sawa A. DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1. Hum. Mol. Genet. 2006, 15:3313-3323.
146. Kanazawa T., Glatt S.J., Kia-Keating B., Yoneda H., Tsuang M.T. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr. Genet. 2007, 17:165-170.
147. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001, 294:1030-1038.
148. Karege F., Perroud N., Schurhoff F., Meary A., Marillier G., Burkhardt S., Ballmann E., Fernandez R., Jamain S., Leboyer M., La Harpe R., Malafosse A. Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder. Genes Brain Behav. 2010, 9:503-511.
149. Kato T., Abe Y., Sotoyama H., Kakita A., Kominami R., Hirokawa S., Ozaki M., Takahashi H., Nawa H. Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Mol. Psychiatry 2010, 10.1038/mp.2010.10.
150. Kegeles L.S., Abi-Dargham A., Zea-Ponce Y., Rodenhiser-Hill J., Mann J.J., Van Heertum R.L., Cooper T.B., Carlsson A., Laruelle M. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol. Psychiatry 2000, 48:627-640.
151. Kim J.Y., Duan X., Liu C.Y., Jang M.H., Guo J.U., Pow-anpongkul N., Kang E., Song H., Ming G.L. DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212. Neuron 2009, 63:761-773.
152. Kim Y.T., Wu C.F. Reduced growth cone motility in cultured neurons from Drosophila memory mutants with a defective cAMP cascade. J. Neurosci. 1996, 16:5593-5602.
153. Koga M., Ishiguro H., Horiuchi Y., Albalushi T., Inada T., Iwata N., Ozaki N., Ujike H., Muratake T., Someya T., Arinami T. Failure to confirm the association between the FEZ1 gene and schizophrenia in a Japanese population. Neurosci. Lett. 2007, 417:326-329.
154. Kohara K., Kitamura A., Adachi N., Nishida M., Itami C., Nakamura S., Tsumoto T. Inhibitory but not excitatory cortical neurons require presynaptic brain-derived neurotrophic factor for dendritic development, as revealed by chimera cell culture. J. Neurosci. 2003, 23:6123-6131.
155. Konishi H., Kuroda S., Tanaka M., Matsuzaki H., Ono Y., Kameyama K., Haga T., Kikkawa U. Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and beta gamma subunits of G proteins. Biochem. Biophys. Res. Commun. 1995, 216:526-534.
156. Konrad A., Vucurevic G., Musso F., Stoeter P., Dahmen N., Winterer G. ErbB4 genotype predicts left frontotemporal structural connectivity in human brain. Neuropsychopharmacology 2009, 34:641-650.
157. Koolschijn P.C., van Haren N.E., Bakker S.C., Hoogendoorn M.L., Pol H.E., Kahn R.S. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus 2009, 20:1010-1017.
158. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 1994, 51:199-214.
159. Kvajo M., McKellar H., Arguello P.A., Drew L.J., Moore H., MacDermott A.B., Karayiorgou M., Gogos J.A. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7076-7081.
160. Kwon O.B., Paredes D., Gonzalez C.M., Neddens J., Hernandez L., Vullhorst D., Buonanno A. Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15587-15592.
161. Kyriakopoulos M., Frangou S. Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr. Opin. Psychiatry 2009, 22:168-176.
162. Lahti A.C., Weiler M.A., Tamara Michaelidis B.A., Parwani A., Tamminga C.A. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 2001, 25:455-467.
163. Lai C., Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 1991, 6:691-704.
164. Lai W.S., Xu B., Westphal K.G., Paterlini M., Olivier B., Pavlidis P., Karayiorgou M., Gogos J.A. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16906-16911.
165. Law A.J., Kleinman J.E., Weinberger D.R., Weickert C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 2007, 16:129-141.
166. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., Harrison P.J., Kleinman J.E., Weinberger D.R. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6747-6752.
167. Layfield R., Fergusson J., Aitken A., Lowe J., Landon M., Mayer R.J. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci. Lett. 1996, 209:57-60.
168. Lee D., O'Dowd D.K. cAMP-dependent plasticity at excitatory cholinergic synapses in Drosophila neurons: alterations in the memory mutant dunce. J. Neurosci. 2000, 20:2104-2111.
169. Levine E.S., Crozier R.A., Black I.B., Plummer M.R. Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10235-10239.
170. Lewis D.A., Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008, 33:141-165.
171. Li B., Woo R.S., Mei L., Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007, 54:583-597.
172. Li D., Collier D.A., He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum. Mol. Genet. 2006, 15:1995-2002.
173. Li W., Zhang Q., Oiso N., Novak E.K., Gautam R., O'Brien E.P., Tinsley C.L., Blake D.J., Spritz R.A., Copeland N.G., Jenkins N.A., Amato D., Roe B.A., Starcevic M., Dell'Angelica E.C., Elliott R.W., Mishra V., Kingsmore S.F., Paylor R.E., Swank R.T. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat. Genet. 2003, 35:84-89.
174. Lipska B.K., Peters T., Hyde T.M., Halim N., Horowitz C., Mitkus S., Weickert C.S., Matsumoto M., Sawa A., Straub R.E., Vakkalanka R., Herman M.M., Weinberger D.R., Kleinman J.E. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet. 2006, 15:1245-1258.
175. Lisman J.E., Coyle J.T., Green R.W., Javitt D.C., Benes F.M., Heckers S., Grace A.A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008, 31:234-242.
176. Liu Y., Ford B., Mann M.A., Fischbach G.D. Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J. Neurosci. 2001, 21:5660-5669.
177. Liu Y., Ford B.D., Mann M.A., Fischbach G.D. Neuregulin-1 increases the proliferation of neuronal progenitors from embryonic neural stem cells. Dev. Biol. 2005, 283:437-445.
178. Liu Y.L., Fann C.S., Liu C.M., Wu J.Y., Hung S.I., Chan H.Y., Chen J.J., Pan C.C., Liu S.K., Hsieh M.H., Hwang T.J., Ouyang W.C., Chen C.Y., Lin J.J., Chou F.H., Chueh C.M., Liu W.M., Tsuang M.M., Faraone S.V., Tsuang M.T., Chen W.J., Hwu H.G. Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population. Psychiatr. Genet. 2006, 16:39-41.
179. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell. Dev. Biol. 2004, 20:781-810.
180. Lopez-Bendito G., Cautinat A., Sanchez J.A., Bielle F., Flames N., Garratt A.N., Talmage D.A., Role L.W., Charnay P., Marin O., Garel S. Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell 2006, 125:127-142.
181. Luby E.D., Cohen B.D., Rosenbaum G., Gottlieb J.S., Kelley R. Study of a new schizophrenomimetic drug; sernyl. AMA Arch. Neurol. Psychiatry 1959, 81:363-369.
182. Luciano M., Miyajima F., Lind P.A., Bates T.C., Horan M., Harris S.E., Wright M.J., Ollier W.E., Hayward C., Pendleton N., Gow A.J., Visscher P.M., Starr J.M., Deary I.J., Martin N.G., Payton A. Variation in the dysbindin gene and normal cognitive function in three independent population samples. Genes Brain Behav. 2009, 8:218-227.
183. Lynch D.R., Guttmann R.P. NMDA receptor pharmacology: perspectives from molecular biology. Curr. Drug Targets 2001, 2:215-231.
184. Ma L., Huang Y.Z., Pitcher G.M., Valtschanoff J.G., Ma Y.H., Feng L.Y., Lu B., Xiong W.C., Salter M.W., Weinberg R.J., Mei L. Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J. Neurosci. 2003, 23:3164-3175.
185. Ma L., Liu Y., Ky B., Shughrue P.J., Austin C.P., Morris J.A. Cloning and characterization of Disc1, the mouse ortholog of DISC1 (Disrupted-in-Schizophrenia 1). Genomics 2002, 80:662-672.
186. Macgregor S., Visscher P.M., Knott S.A., Thomson P., Porteous D.J., Millar J.K., Devon R.S., Blackwood D., Muir W.J. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol. Psychiatry 2004, 9:1083-1090.
187. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., Tassa C., Berry E.M., Soda T., Singh K.K., Biechele T., Petryshen T.L., Moon R.T., Haggarty S.J., Tsai L.H. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009, 136:1017-1031.
188. Markov V., Krug A., Krach S., Jansen A., Eggermann T., Zerres K., Stocker T., Shah N.J., Nothen M.M., Treutlein J., Rietschel M., Kircher T. Impact of schizophrenia-risk gene dysbindin 1 on brain activation in bilateral middle frontal gyrus during a working memory task in healthy individuals. Hum. Brain Mapp. 2009, 31:266-275.
189. McIntosh A.M., Moorhead T.W., Job D., Lymer G.K., Munoz Maniega S., McKirdy J., Sussmann J.E., Baig B.J., Bastin M.E., Porteous D., Evans K.L., Johnstone E.C., Lawrie S.M., Hall J. The effects of a neuregulin 1 variant on white matter density and integrity. Mol. Psychiatry 2008, 13:1054-1059.
190. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 2008, 9:437-452.
191. Messaoudi E., Kanhema T., Soule J., Tiron A., Dagyte G., da Silva B., Bramham C.R. Sustained Arc/Arg3.1 synthesis controls long-term potentiation consolidation through regulation of local actin polymerization in the dentate gyrus in vivo. J. Neurosci. 2007, 27:10445-10455.
192. Meyer D., Yamaai T., Garratt A., Riethmacher-Sonnenberg E., Kane D., Theill L.E., Birchmeier C. Isoform-specific expression and function of neuregulin. Development 1997, 124:3575-3586.
193. Millar J.K., Christie S., Anderson S., Lawson D., Hsiao-Wei Loh D., Devon R.S., Arveiler B., Muir W.J., Blackwood D.H., Porteous D.J. Genomic structure and localisation within a linkage hotspot of disrupted in schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol. Psychiatry 2001, 6:173-178.
194. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J.C., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H., Muir W.J., Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310:1187-1191.
195. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 2000, 9:1415-1423.
196. Minichiello L. TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci. 2009, 10:850-860.
197. Miyoshi K., Asanuma M., Miyazaki I., Diaz-Corrales F.J., Katayama T., Tohyama M., Ogawa N. DISC1 localizes to the centrosome by binding to kendrin. Biochem. Biophys. Res. Commun. 2004, 317:1195-1199.
198. Miyoshi K., Honda A., Baba K., Taniguchi M., Oono K., Fujita T., Kuroda S., Katayama T., Tohyama M. Disrupted-in-schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol. Psychiatry 2003, 8:685-694.
199. Mizuno K., Carnahan J., Nawa H. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev. Biol. 1994, 165:243-256.
200. Morris J.A., Kandpal G., Ma L., Austin C.P. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum. Mol. Genet. 2003, 12:1591-1608.
201. Mowla S.J., Pareek S., Farhadi H.F., Petrecca K., Fawcett J.P., Seidah N.G., Morris S.J., Sossin W.S., Murphy R.A. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J. Neurosci. 1999, 19:2069-2080.
202. Muglia P., Vicente A.M., Verga M., King N., Macciardi F., Kennedy J.L. Association between the BDNF gene and schizophrenia. Mol. Psychiatry 2003, 8:146-147.
203. Munafo M.R., Attwood A.S., Flint J. Neuregulin 1 genotype and schizophrenia. Schizophr. Bull. 2008, 34:9-12.
204. Munafo M.R., Thiselton D.L., Clark T.G., Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol. Psychiatry 2006, 11:539-546.
205. Murase S., Mosser E., Schuman E.M. Depolarization drives beta-catenin into neuronal spines promoting changes in synaptic structure and function. Neuron 2002, 35:91-105.
206. Murdoch H., Mackie S., Collins D.M., Hill E.V., Bolger G.B., Klussmann E., Porteous D.J., Millar J.K., Houslay M.D. Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci. 2007, 27:9513-9524.
207. Murthy S.S., Tosolini A., Taguchi T., Testa J.R. Mapping of AKT3, encoding a member of the Akt/protein kinase B family, to human and rodent chromosomes by fluorescence in situ hybridization. Cytogenet. Cell. Genet. 2000, 88:38-40.
208. Mutsuddi M., Morris D.W., Waggoner S.G., Daly M.J., Scolnick E.M., Sklar P. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am. J. Hum. Genet. 2006, 79:903-909.
209. Nagappan G., Zaitsev E., Senatorov V.V., Yang J., Hempstead B.L., Lu B. Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1267-1272.
210. Nakata H., Nakamura S. Brain-derived neurotrophic factor regulates AMPA receptor trafficking to post-synaptic densities via IP3R and TRPC calcium signaling. FEBS Lett. 2007, 581:2047-2054.
211. Nakata K., Lipska B.K., Hyde T.M., Ye T., Newburn E.N., Morita Y., Vakkalanka R., Barenboim M., Sei Y., Weinberger D.R., Kleinman J.E. DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15873-15878.
212. Nanko S., Kunugi H., Hirasawa H., Kato N., Nabika T., Kobayashi S. Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 2003, 62:281-283.
213. Nazarian R., Starcevic M., Spencer M.J., Dell'Angelica E.C. Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein. Biochem. J. 2006, 395:587-598.
214. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., Sinclair M., Crombie C., Walker N., St Clair D.M. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 2005, 10:208-212.
215. Nicodemus K.K., Law A.J., Luna A., Vakkalanka R., Straub R.E., Kleinman J.E., Weinberger D.R. A 5′ promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression. Mol. Psychiatry 2009, 14:741-743.
216. Niwa M., Kamiya A., Murai R., Kubo K., Gruber A.J., Tomita K., Lu L., Tomisato S., Jaaro-Peled H., Seshadri S., Hiyama H., Huang B., Kohda K., Noda Y., O'Donnell P., Nakajima K., Sawa A., Nabeshima T. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 2010, 65:480-489.
217. Niznikiewicz M.A., Kubicki M., Shenton M.E. Recent structural and functional imaging findings in schizophrenia. Curr. Opin. Psychiatry 2003, 16:123-147.
218. Norton N., Williams H.J., Dwyer S., Carroll L., Peirce T., Moskvina V., Segurado R., Nikolov I., Williams N.M., Ikeda M., Iwata N., Owen M.J., O'Donovan M.C. Association analysis of AKT1 and schizophrenia in a UK case control sample. Schizophr Res. 2007, 93:58-65.
219. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., Ozaki N., Taguchi T., Tatsumi M., Kamijima K., Straub R.E., Weinberger D.R., Kunugi H., Hashimoto R. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 2004, 13:2699-2708.
220. O'Donnell J.M., Zhang H.T. Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol. Sci. 2004, 25:158-163.
221. O'Donovan M.C., Owen M.J. Candidate-gene association studies of schizophrenia. Am. J. Hum. Genet. 1999, 65:587-592.
222. Ohtsuki T., Inada T., Arinami T. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol. Psychiatry 2004, 9:981-983.
223. Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J., Wolozin B. alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 1999, 19:5782-5791.
224. Ou L.C., Gean P.W. Regulation of amygdala-dependent learning by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol-3-kinase. Neuropsychopharmacology 2006, 31:287-296.
225. Ozaki M., Sasner M., Yano R., Lu H.S., Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 1997, 390:691-694.
226. Ozeki Y., Tomoda T., Kleiderlein J., Kamiya A., Bord L., Fujii K., Okawa M., Yamada N., Hatten M.E., Snyder S.H., Ross C.A., Sawa A. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:289-294.
227. Pan W., Banks W.A., Fasold M.B., Bluth J., Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1561.
228. Perala J., Suvisaari J., Saarni S.I., Kuoppasalmi K., Isometsa E., Pirkola S., Partonen T., Tuulio-Henriksson A., Hintikka J., Kieseppa T., Harkanen T., Koskinen S., Lonnqvist J. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 2007, 64:19-28.
229. Pickard B.S., Thomson P.A., Christoforou A., Evans K.L., Morris S.W., Porteous D.J., Blackwood D.H., Muir W.J. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr. Genet. 2007, 17:129-133.
230. Pitcher G.M., Beggs S., Woo R.S., Mei L., Salter M.W. ErbB4 is a suppressor of long-term potentiation in the adult hippocampus. Neuroreport 2008, 19:139-143.
231. Potkin S.G., Turner J.A., Brown G.G., McCarthy G., Greve D.N., Glover G.H., Manoach D.S., Belger A., Diaz M., Wible C.G., Ford J.M., Mathalon D.H., Gollub R., Lauriello J., O'Leary D., van Erp T.G., Toga A.W., Preda A., Lim K.O. Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophr. Bull. 2009, 35:19-31.
232. Proschel M., Saunders A., Roses A.D., Muller C.R. Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). Hum. Mol. Genet. 1992, 1:353.
233. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
234. Radant A.D., Bowdle T.A., Cowley D.S., Kharasch E.D., Roy-Byrne P.P. Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?. Neuropsychopharmacology 1998, 19:434-444.
235. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry 1998, 55:215-224.
236. Rasser P.E., Schall U., Todd J., Michie P.T., Ward P.B., Johnston P., Helmbold K., Case V., Soyland A., Tooney P.A., Thompson P.M. Gray matter deficits mismatch negativity, and outcomes in schizophrenia. Schizophr. Bull. 2009, 10.1093/schbul/sbp060.
237. Rastogi A., Zai C., Likhodi O., Kennedy J.L., Wong A.H. Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia. Schizophr. Res. 2009, 114:39-49.
238. Reichardt L.F. Neurotrophin-regulated signalling pathways. Philos. Trans. R Soc. Lond. B Biol. Sci. 2006, 361:1545-1564.
239. Reichardt L.F., Tomaselli K.J. Extracellular matrix molecules and their receptors: functions in neural development. Annu. Rev. Neurosci. 1991, 14:531-570.
240. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., Lesch K.P. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol. Psychiatry 2006, 11:514-522.
241. Riley B., Kuo P.H., Maher B.S., Fanous A.H., Sun J., Wormley B., O'Neill F.A., Walsh D., Zhao Z., Kendler K.S. The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr. Res. 2009, 115:245-253.
242. Rizos E.N., Rontos I., Laskos E., Arsenis G., Michalopoulou P.G., Vasilopoulos D., Gournellis R., Lykouras L. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1308-1311.
243. Rosa A., Gardner M., Cuesta M.J., Peralta V., Fatjo-Vilas M., Miret S., Navarro M.E., Comas D., Fananas L. Family-based association study of neuregulin-1 gene and psychosis in a Spanish sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B:954-957.
244. Rosch H., Schweigreiter R., Bonhoeffer T., Barde Y.A., Korte M. The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7362-7367.
245. Rose C.R., Blum R., Pichler B., Lepier A., Kafitz K.W., Konnerth A. Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature 2003, 426:74-78.
246. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M., Coyle J.T. Neurobiology of schizophrenia. Neuron 2006, 52:139-153.
247. Roy K., Murtie J.C., El-Khodor B.F., Edgar N., Sardi S.P., Hooks B.M., Benoit-Marand M., Chen C., Moore H., O'Donnell P., Brunner D., Corfas G. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:8131-8136.
248. Russo S.J., Mazei-Robison M.S., Ables J.L., Nestler E.J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 2009, 56(Suppl. 1):73-82.
249. Sakata K., Woo N.H., Martinowich K., Greene J.S., Schloesser R.J., Shen L., Lu B. Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5942-5947.
250. Sala R., Viegi A., Rossi F.M., Pizzorusso T., Bonanno G., Raiteri M., Maffei L. Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur. J. Neurosci. 1998, 10:2185-2191.
251. Sawa A., Snyder S.H. Genetics. Two genes link two distinct psychoses. Science 2005, 310:1128-1129.
252. Schmid R.S., McGrath B., Berechid B.E., Boyles B., Marchionni M., Sestan N., Anton E.S. Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4251-4256.
253. Schurov I.L., Handford E.J., Brandon N.J., Whiting P.J. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol. Psychiatry 2004, 9:1100-1110.
254. Schwab S.G., Hoefgen B., Hanses C., Hassenbach M.B., Albus M., Lerer B., Trixler M., Maier W., Wildenauer D.B. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol. Psychiatry 2005, 58:446-450.
255. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., Lerer B., Rietschel M., Trixler M., Maier W., Wildenauer D.B. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 2003, 72:185-190.
256. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 1999, 45:17-25.
257. Seshadri S., Kamiya A., Yokota Y., Prikulis I., Kano S., Hayashi-Takagi A., Stanco A., Eom T.Y., Rao S., Ishizuka K., Wong P., Korth C., Anton E.S., Sawa A. Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5622-5627.
258. Shamir A., Buonanno A. Molecular and cellular characterization of Neuregulin-1 type IV isoforms. J. Neurochem. 2010, 113:1163-1176.
259. Shimizu S., Matsuzaki S., Hattori T., Kumamoto N., Miyoshi K., Katayama T., Tohyama M. DISC1-kendrin interaction is involved in centrosomal microtubule network formation. Biochem. Biophys. Res. Commun. 2008, 377:1051-1056.
260. Shinoda T., Taya S., Tsuboi D., Hikita T., Matsuzawa R., Kuroda S., Iwamatsu A., Kaibuchi K. DISC1 regulates neurotrophin-induced axon elongation via interaction with Grb2. J. Neurosci. 2007, 27:4-14.
261. Shu T., Ayala R., Nguyen M.D., Xie Z., Gleeson J.G., Tsai L.H. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 2004, 44:263-277.
262. Silberberg G., Darvasi A., Pinkas-Kramarski R., Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:142-148.
263. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., Gosden C., Evans H.J. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336:13-16.
264. Stanley J.A., Williamson P.C., Drost D.J., Carr T.J., Rylett R.J., Malla A., Thompson R.T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiatry 1995, 52:399-406.
265. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
266. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O'Neill F.A., Walsh D., Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 2002, 71:337-348.
267. Strohmaier J., Frank J., Wendland J.R., Schumacher J., Jamra R.A., Treutlein J., Nieratschker V., Breuer R., Mattheisen M., Herms S., Muhleisen T.W., Maier W., Nothen M.M., Cichon S., Rietschel M., Schulze T.G. A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry. Schizophr. Res. 2010, 118:98-105.
268. Sweet R.A., Henteleff R.A., Zhang W., Sampson A.R., Lewis D.A. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 2008, 34:374-389.
269. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi S., Wakabayashi K., Takahashi H., Someya T., Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 2000, 5:293-300.
270. Takahashi T., Suzuki M., Tsunoda M., Kawamura Y., Takahashi N., Tsuneki H., Kawasaki Y., Zhou S.Y., Kobayashi S., Sasaoka T., Seto H., Kurachi M., Ozaki N. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci. Lett. 2008, 435:34-39.
271. Takao K., Toyama K., Nakanishi K., Hattori S., Takamura H., Takeda M., Miyakawa T., Hashimoto R. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol. Brain 2008, 1:11.
272. Talbot K., Cho D.S., Ong W.Y., Benson M.A., Han L.Y., Kazi H.A., Kamins J., Hahn C.G., Blake D.J., Arnold S.E. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum. Mol. Genet. 2006, 15:3041-3054.
273. Talbot K., Eidem W.L., Tinsley C.L., Benson M.A., Thompson E.W., Smith R.J., Hahn C.G., Siegel S.J., Trojanowski J.Q., Gur R.E., Blake D.J., Arnold S.E. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 2004, 113:1353-1363.
274. Tan H.Y., Nicodemus K.K., Chen Q., Li Z., Brooke J.K., Honea R., Kolachana B.S., Straub R.E., Meyer-Lindenberg A., Sei Y., Mattay V.S., Callicott J.H., Weinberger D.R. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J. Clin. Invest. 2008, 118:2200-2208.
275. Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., Weinberger D.R., Law A.J. Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J. Biol. Chem. 2007, 282:24343-24351.
276. Tang J., LeGros R.P., Louneva N., Yeh L., Cohen J.W., Hahn C.G., Blake D.J., Arnold S.E., Talbot K. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Hum. Mol. Genet. 2009, 18:3851-3863.
277. Tang T.T., Yang F., Chen B.S., Lu Y., Ji Y., Roche K.W., Lu B. Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21395-21400.
278. Taya S., Shinoda T., Tsuboi D., Asaki J., Nagai K., Hikita T., Kuroda S., Kuroda K., Shimizu M., Hirotsune S., Iwamatsu A., Kaibuchi K. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J. Neurosci. 2007, 27:15-26.
279. Tepass U., Truong K., Godt D., Ikura M., Peifer M. Cadherins in embryonic and neural morphogenesis. Nat. Rev. Mol. Cell. Biol. 2000, 1:91-100.
280. Thiselton D.L., Vladimirov V.I., Kuo P.H., McClay J., Wormley B., Fanous A., O'Neill F.A., Walsh D., Van den Oord E.J., Kendler K.S., Riley B.P. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol. Psychiatry 2008, 63:449-457.
281. Thiselton D.L., Webb B.T., Neale B.M., Ribble R.C., O'Neill F.A., Walsh D., Riley B.P., Kendler K.S. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol. Psychiatry 2004, 9:777-783. image 729.
282. Thomson P.A., Harris S.E., Starr J.M., Whalley L.J., Porteous D.J., Deary I.J. Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci. Lett. 2005, 389:41-45.
283. Timmusk T., Palm K., Metsis M., Reintam T., Paalme V., Saarma M., Persson H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 1993, 10:475-489.
284. Tomppo L., Hennah W., Lahermo P., Loukola A., Tuulio-Henriksson A., Suvisaari J., Partonen T., Ekelund J., Lonnqvist J., Peltonen L. Association between genes of disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses. Biol. Psychiatry 2009, 65:1055-1062.
285. Tsai G.E., Lin P.Y. Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr. Pharm. Des. 2010, 16:522-537.
286. Tsien J.Z. Linking Hebb's coincidence-detection to memory formation. Curr. Opin. Neurobiol. 2000, 10:266-273.
287. Turunen J.A., Peltonen J.O., Pietilainen O.P., Hennah W., Loukola A., Paunio T., Silander K., Ekelund J., Varilo T., Partonen T., Lonnqvist J., Peltonen L. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr. Res. 2007, 91:27-36.
288. Tyler W.J., Pozzo-Miller L.D. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J. Neurosci. 2001, 21:4249-4258.
289. Umbricht D., Schmid L., Koller R., Vollenweider F.X., Hell D., Javitt D.C. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiatry 2000, 57:1139-1147.
290. van den Oord E.J., Sullivan P.F., Jiang Y., Walsh D., O'Neill F.A., Kendler K.S., Riley B.P. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol. Psychiatry 2003, 8:499-510.
291. Vicario-Abejon C., Collin C., McKay R.D., Segal M. Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons. J. Neurosci. 1998, 18:7256-7271.
292. Virgos C., Martorell L., Valero J., Figuera L., Civeira F., Joven J., Labad A., Vilella E. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 2001, 49:65-71.
293. Vullhorst D., Neddens J., Karavanova I., Tricoire L., Petralia R.S., McBain C.J., Buonanno A. Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J. Neurosci. 2009, 29:12255-12264.
294. Walker R.M., Christoforou A., Thomson P.A., McGhee K.A., Maclean A., Muhleisen T.W., Strohmaier J., Nieratschker V., Nothen M.M., Rietschel M., Cichon S., Morris S.W., Jilani O., Stclair D., Blackwood D.H., Muir W.J., Porteous D.J., Evans K.L. Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci. Lett. 2010, 478:9-13.
295. Wayman G.A., Lee Y.S., Tokumitsu H., Silva A., Soderling T.R. Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron 2008, 59:914-931.
296. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 2003, 8:592-610.
297. Weickert C.S., Ligons D.L., Romanczyk T., Ungaro G., Hyde T.M., Herman M.M., Weinberger D.R., Kleinman J.E. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 2005, 10:637-650.
298. Weickert C.S., Rothmond D.A., Hyde T.M., Kleinman J.E., Straub R.E. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr. Res. 2008, 98:105-110.
299. Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., Hashimoto R., Hyde T.M., Herman M.M., Weinberger D.R., Kleinman J.E. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry 2004, 61:544-555.
300. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
301. Wen L., Lu Y.S., Zhu X.H., Li X.M., Woo R.S., Chen Y.J., Yin D.M., Lai C., Terry A.V., Vazdarjanova A., Xiong W.C., Mei L. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1211-1216.
302. Wessman J., Paunio T., Tuulio-Henriksson A., Koivisto M., Partonen T., Suvisaari J., Turunen J.A., Wedenoja J., Hennah W., Pietilainen O.P., Lonnqvist J., Mannila H., Peltonen L. Mixture model clustering of phenotype features reveals evidence for association of DTNBP1 to a specific subtype of schizophrenia. Biol. Psychiatry 2009, 66:990-996.
303. Williams N.M., Preece A., Morris D.W., Spurlock G., Bray N.J., Stephens M., Norton N., Williams H., Clement M., Dwyer S., Curran C., Wilkinson J., Moskvina V., Waddington J.L., Gill M., Corvin A.P., Zammit S., Kirov G., Owen M.J., O'Donovan M.C. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch. Gen. Psychiatry 2004, 61:336-344.
304. Winterer G., Konrad A., Vucurevic G., Musso F., Stoeter P., Dahmen N. Association of 5′ end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans. Neuroimage 2008, 40:712-718.
305. Wirgenes K.V., Djurovic S., Agartz I., Jonsson E.G., Werge T., Melle I., Andreassen O.A. Dysbindin and d-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia. Neuropsychobiology 2009, 60:31-36.
306. Wong J., Hyde T.M., Cassano H.L., Deep-Soboslay A., Kleinman J.E., Weickert C.S. Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience 2010, 169:1071-1084.
307. Woo N.H., Lu B. Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 2006, 12:43-56.
308. Woo N.H., Teng H.K., Siao C.J., Chiaruttini C., Pang P.T., Milner T.A., Hempstead B.L., Lu B. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 2005, 8:1069-1077.
309. Woo R.S., Li X.M., Tao Y., Carpenter-Hyland E., Huang Y.Z., Weber J., Neiswender H., Dong X.P., Wu J., Gassmann M., Lai C., Xiong W.C., Gao T.M., Mei L. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 2007, 54:599-610.
310. Wood J.D., Bonath F., Kumar S., Ross C.A., Cunliffe V.T. Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. Hum. Mol. Genet. 2009, 18:391-404.
311. Xu M.Q., St Clair D., Ott J., Feng G.Y., He L. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr. Res. 2007, 91:6-13.
312. Xu M.Q., Xing Q.H., Zheng Y.L., Li S., Gao J.J., He G., Guo T.W., Feng G.Y., Xu F., He L. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J. Clin. Psychiatry 2007, 68:1358-1367.
313. Yamada K., Nakamura K., Minabe Y., Iwayama-Shigeno Y., Takao H., Toyota T., Hattori E., Takei N., Sekine Y., Suzuki K., Iwata Y., Miyoshi K., Honda A., Baba K., Katayama T., Tohyama M., Mori N., Yoshikawa T. Association analysis of FEZ1 variants with schizophrenia in Japanese cohorts. Biol. Psychiatry 2004, 56:683-690.
314. Yamada M.K., Nakanishi K., Ohba S., Nakamura T., Ikegaya Y., Nishiyama N., Matsuki N. Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J. Neurosci. 2002, 22:7580-7585.
315. Yang X., Kuo Y., Devay P., Yu C., Role L. A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis. Neuron 1998, 20:255-270.
316. Yau H.J., Wang H.F., Lai C., Liu F.C. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb. Cortex 2003, 13:252-264.
317. Young-Pearse T.L., Bai J., Chang R., Zheng J.B., LoTurco J.J., Selkoe D.J. A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J. Neurosci. 2007, 27:14459-14469.
318. Young-Pearse T.L., Suth S., Luth E.S., Sawa A., Selkoe D.J. Biochemical and functional interaction of disrupted-in-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development. J. Neurosci. 2010, 30:10431-10440.
319. Zhang X.Y., Tan Y.L., Zhou D.F., Cao L.Y., Wu G.Y., Xu Q., Shen Y., Haile C.N., Kosten T.A., Kosten T.R. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. J. Psychiatr. Res. 2007, 41:997-1004.
320. Zhou X., Chen Q., Schaukowitch K., Kelsoe J.R., Geyer M.A. Insoluble DISC1-Boymaw fusion proteins generated by DISC1 translocation. Mol. Psychiatry 2010, 15:669-672.
321. Zhou X., Geyer M.A., Kelsoe J.R. Does disrupted-in-schizophrenia (DISC1) generate fusion transcripts?. Mol. Psychiatry 2008, 13:361-363.